talazoparib

FDA approves Pfizer's drug for advanced breast cancer
Reuters
Tue, 10/16/18 - 08:40 pm
FDA
Pfizer
PARP inhibitors
talazoparib
breast cancer
BRCA-mutant breast cancer
Myriad and Pfizer Sign Deal to Commercialize Companion Diagnostic
CP Wire
Tue, 10/9/18 - 10:52 am
Myriad Genetics
Pfizer
talazoparib
BRACAnalysis CDx
Myriad and Pfizer Sign Deal to Commercialize Companion Diagnostic
Tue, 10/9/18 - 09:44 am
Myriad Genetics
Pfizer
talazoparib
BRACAnalysis CDx
Myriad Genetics Wins FDA SPMA Nod for BRACAnalysis CDx
Yahoo/Zacks.com
Tue, 06/19/18 - 10:19 pm
Myriad Genetics
FDA
BRACAnalysis CDx
diagnostics
Pfizer
talazoparib
Can This Pharma's $14 Billion Bet Succeed?
Motley Fool
Tue, 06/12/18 - 09:39 am
Pfizer
M&A
Medivation
Xtandi
talazoparib
Pfizer's PARP Inhibitor Talazoparib Gets FDA Priority Review and EMA Submission
CP Wire
Thu, 06/7/18 - 12:07 pm
Pfizer
talazoparib
BRCA-mutant breast cancer
breast cancer
metastatic breast cancer
FDA
EMA
priority review
Pfizer's PARP Inhibitor Talazoparib Gets FDA Priority Review and EMA Submission
Thu, 06/7/18 - 12:04 pm
Pfizer
talazoparib
BRCA-mutant breast cancer
breast cancer
How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment
Motley Fool
Thu, 03/15/18 - 09:55 am
cancer
oncology
Pfizer
Ibrance
breast cancer
Xtandi
prostate cancer
Bavencio
bladder cancer
Merkel cell carcinoma
lorlatinib
metastatic non-small cell lung cancer
talazoparib
metastatic breast cancer
Array Biopharma ties up with Pfizer on cancer-fighting combos
Fierce Biotech
Wed, 12/20/17 - 09:51 am
Array Biopharma
Pfizer
clinical trials
binimetinib
talazoparib
Merck KGaA
Bavencio
cancer
A New PARP Drug For Breast Cancer
Forbes
Mon, 12/18/17 - 10:13 am
PARP inhibitors
breast cancer
metastatic breast cancer
talazoparib
Pfizer
In a showdown with AstraZeneca, Pfizer posts solid — and very familiar — PhIII breast cancer data for talazoparib
Endpoints
Fri, 12/8/17 - 11:46 am
Pfizer
AstraZeneca
talazoparib
advanced breast cancer
Lynparza
PARP inhibitors
What Pfizer Gets in Its $14 Billion Medivation Deal
Motley Fool
Tue, 08/23/16 - 10:02 am
Pfizer
Medivation
M&A
Xtandi
prostate cancer
talazoparib
pidilizumab
Pfizer spent $14 billion on a company with just one approved drug — here's why that's a game changer
Yahoo/Business Insider
Mon, 08/22/16 - 11:45 am
Pfizer
Medivation
M&A
Sanofi
Xtandi
prostate cancer
pidilizumab
talazoparib
Buyout target Medivation says cancer drug could be "best in class"
Yahoo/Reuters
Wed, 07/6/16 - 09:52 pm
Medivation
talazoparib
PARP inhibitors
Sanofi
M&A
Medivation: It’s Not Just M&A
Barron's
Mon, 04/18/16 - 10:15 am
Medivation
M&A
AstraZenca
Sanofi
Gilead Sciences
talazoparib
PARP inhibitors
3 Cancer Companies to Watch Closely in 2016
Motley Fool
Tue, 10/20/15 - 10:00 am
cancer
Celldex
Medivation
Clovis Oncology
rociletinib
talazoparib
Rintega
Medivation Destined To Become A Biotech Behemoth As Low-Risk Pipeline Expands
Seeking Alpha
Wed, 09/2/15 - 12:43 pm
talazoparib
Medivation
Xtandi
pidilizumab
BioMarin sells its PhIII cancer drug to Medivation for $570M
Fierce Biotech
Mon, 08/24/15 - 11:22 am
Biomarin
Medivation
talazoparib
breast cancer
BRCA1
BRCA2